← Leaderboards
Kevin D'amour
Viacyte, Inc.
$954,590
Attributed
$954,590
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500.4K · FY2017–18$1M$750K$500K$250K$0
'17
'18
Funding mix
By agency
NIH$954,590 · 1
By mechanism
R44$954,590 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Diabetes Mellitus Therapy”
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$12,611,499
- Kristina H Lewis · Harvard Pilgrim Health Care, Inc.$7,353,754
- Mara Becker · Duke University$6,798,777
- Pawel Fludzinski · Amidebio, Llc$6,179,544
Research focus
Diabetes Mellitus TherapyBaseBeta CellDiabetes MellitusBlood Glucose RegulationCell Differentiation ProcessCell LineageCell PhysiologyBioreactorsAdoptedCharacteristicsChronicClinicClinical TrialsCommercializationCompetenceCostC-PeptideCryopreservationCellsCell TherapyDetectionDevicesDiabetic Patient